Evidence map›Paper›PMID 29731961›Full record

ArticleOncotarget2018

Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.

Kari Trumpi, Nicola Frenkel, Timo Peters, Nicoline M Korthagen, Jennifer M J Jongen, Daniëlle Raats, Helma van Grevenstein, Yara Backes, Leon M Moons, Miangela M Lacle and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Newly developed 3D in vitro models to study tumor-immune interaction.Journal of experimental & clinical cancer research : CR · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kari Trumpi *UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Nicola Frenkel *UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Timo PetersUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Nicoline M KorthagenOrthopedics, University Medical Center Utrecht, Utrecht, The Netherlands.
Jennifer M J JongenUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Daniëlle RaatsUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Helma van GrevensteinUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Yara BackesGastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
Leon M MoonsGastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
Miangela M LaclePathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Jan KosterDepartment of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Danny ZwijnenburgDepartment of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Inne H M Borel RinkesUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Onno KranenburgUMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary human colorectal tumors with a high stromal content have an increased capacity to metastasize. Cancer-associated fibroblasts (CAFs) promote metastasis, but the contribution of other stromal cell types is unclear. Here we searched for additional stromal cell types that contribute to aggressive tumor cell behavior. By making use of the 'immunome compendium'-a collection of gene signatures reflecting the presence of specific immune cell-types-we show that macrophage signatures are most strongly associated with a high CAF content and with poor prognosis in multiple large cohorts of primary tumors and liver metastases. Co-culturing macrophages with patient-derived colonospheres promoted 'budding' of small clusters of tumor cells from the bulk. Immunohistochemistry showed that budding tumor clusters in stroma-rich areas of T1 colorectal carcinomas were surrounded by macrophages.

Indexed as

buddingcolorectalconsensus molecular subtypesmatrix metalloproteasemetastasis

Identifiers

PMID29731961
PMCPMC5929404
OpenAlexW2797374046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.